Navigation Links
Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement
Date:6/30/2017

Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, and Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, announced a multi-disciplinary research collaboration with the FSBI Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences (http://www.academpharm.ru/), and the Pavlov Institute of Physiology of the Russian Academy of Sciences (http://www.infran.ru/), to jointly study the pharmacotherapeutic longevity enhancement properties of its combinatorial regenerative biologic candidates.

“We are very excited about this continued collaboration with Lakmus,” said Ira S. Pastor, CEO, Bioquark Inc. “The disciplined development of our combinatorial biologic candidates (Bioquantines) for healthy longevity enhancement, represents another important step in our continued evolution as a company focused on a broad range of therapeutic products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

The integration of a complex set of newer research disciplines, including interkingdom signaling, semiochemical communication, and evolutionary biology, as well as significant recent activity in the areas of the microbiome, are highlighting a myriad of new ways that non-human bio-products can affect the human genome for positive transitions in health and wellness dynamics.

“Bioquark has spent several years studying the natural ability of many species to turn back biological time in order to maintain health, fitness, and survival, developing a broad understanding of the combinatorial biochemical approaches they use to control nested hierarchies of disease (i.e. gene, cell, tissue, organism, environment),” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This research initiative is one more step in the path in allowing humans to recapture these capabilities to effectively counter our unfortunate progression into aging, disease and degeneration.”

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14471477.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells
2. Bioquark Inc. Announces Approval of Bioquantine Bio-Active Food Additives in Eurasian Customs Union
3. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
4. Annual Conference about Technology Solutions for People with Disabilities Announces Program
5. Probiotic Action Announces Probiotics Lead the Digestive Health Market
6. Verenium Announces Preliminary Financial Results For Fiscal 2012
7. DMG is Proud to Announce that CD Diagnostics will be Featured in an Upcoming Episode of Health Heroes
8. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
9. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
10. EAG Announces New General Manager of Release-To-Production (RTP) Division
11. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... ... ... The incredible life story of former refugee and LG Sonic CEO Yousef ... the European Commissioner for Research and Innovation. , In his November 27th speech ... spoke at length of Yousef’s life and journey, citing the man who convinced him ...
(Date:11/28/2018)... (PRWEB) , ... November 28, 2018 , ... Earlier this ... Italian cuisine, as well as experience the height of truffle season. , ... food and pristine countryside. Staying in the exclusive Black Truffle Lodge in the small ...
(Date:11/20/2018)... ... November 19, 2018 , ... Patients with missing teeth in ... implants from Dr. Dan Myers at THE DENTIST Centers without a referral. Dr. ... restorations for the last 20 years. He now offers skilled dental care in two ...
(Date:11/13/2018)... ... November 13, 2018 , ... Renowned Honolulu veterinarian, Dr. Patrick Leadbeater, has begun ... Dr. Leadbeater, of Kahala Pet Hospital on Oahu, is a skilled ... traveling to the island of Kauai on an almost weekly basis to perform surgery ...
Breaking Biology Technology:
(Date:11/27/2018)... ... November 27, 2018 , ... ... David Pepe, P.E., as Chief Operating Officer (COO). Dave joins the executive ... direct the company’s internal functions. Dave will also serve in a key ...
(Date:11/27/2018)... ... , ... PulseEd™ uses researched technology, published in the Journal of Sexual ... to the penis. Regular and unimpeded blood flow to the blood vessels of the ... The recorded results of SWT (sound wave therapy), indicated that almost 80% of men ...
(Date:11/27/2018)... ... November 27, 2018 , ... LabArchives ... worked together to integrate the LabArchives Classroom Edition with Current Protocols Essential Laboratory ... be available beginning January of 2019. , The integration of LabArchives ...
Breaking Biology News(10 mins):